Transcriptional activation of the cyclin D1 by oncogenic Ras appears to be mediated by several pathways leading to the activation of multiple transcription factors which interact with distinct elements of the cyclin D1 promoter. The present investigations revealed that cyclin D1 induction by transforming Ha-Ras is MEKand Rac-dependent and requires the PKC isotypes ⑀, , and , but not cPKC-␣. This conclusion is based on observations indicating that cyclin D1 induction by transforming Ha-Ras was depressed in a dose-dependent manner by PD98059, a selective inhibitor of the mitogenactivated kinase kinase MEK-1, demonstrating that HaRas employs extracellular signal-regulated kinases (ERKs) for signal transmission to the cyclin D1 promoter. Evidence is presented that PKC isotypes ⑀ and , but not are required for the Ras-mediated activation of ERKs. Expression of kinase-defective, dominant negative (DN) mutants of nPKC-⑀ or aPKC-inhibit ERK activation by constitutively active Raf-1. Phosphorylation within the TEY motif and subsequent activation of ERKs by constitutively active MEK-1 was significantly inhibited by DN aPKC-, indicating that aPKC-functions downstream of MEK-1 in the pathway leading to cyclin D1 induction. In contrast, TEY phosphorylation induced by constitutively active MEK-1 was not effected by nPKC-⑀, suggesting another position for this kinase within the cascade investigated. Transformation by oncogenic Ras requires activation of several Ras effector pathways which may be PKC-dependent and converge on the cyclin D1 promoter. Therefore, we investigated a role for PKC isotypes in the Ras-Rac-mediated transcriptional regulation of cyclin D1. We have been able to reveal that cyclin D1 induction by oncogenic Ha-Ras is Rac-dependent and requires the PKC isotypes ⑀, , and , but not cPKC-␣. Evidence is presented that aPKC-acts upstream of Rac, between Ras and Rac, whereas the PKC isotypes ⑀ and act downstream of Rac and are required for the activation of ERKs.Transformation by oncogenic Ras requires activation of several Ras effectors which, in turn, stimulate different signaling pathways. These Ras effectors include Raf, Ral-GDS, PI 3-kinase, and Rac-1 (1). Activation of Rac-1 by oncogenic Ras is mediated by PI 3-kinase 1 -dependent (2, 3) and PI 3-kinaseindependent mechanisms (2). These Ras effector pathways may converge on the cyclin D1 promoter (1, 4). Evidence for a positive regulation of the cyclin D1 promoter by Ras has been presented (4 -7).The Ras-Raf-ERK cascade has been described as the dominant pathway by which Ras transmits signals to the cyclin D1 promoter (4, 8 -10), although in nontransformed cells the situation may be different (1). One effect of the stimulation of ERK1 by Ras seems to be the activation of Ets-2, since expression of plasmids encoding DN Ets (Ets-LacZ) antagonized ERKdependent activation of the cyclin D1 promoter (4) and mutation of an Ets-binding site (termed EtsB (6)) strongly reduced basal and also Ras-induced activation of cyclin D1.Another Ras effector, Rac-1, has also been...